Biohaven is outlicensing to SK Biopharmaceuticals global rights to opakalim, a Kv7-targeting small molecule in pivotal clinical testing for epilepsy. Biohaven gets non-dilutive financing for its pipeline while SK Bio gains another asset to potentially commercialize in the U.S. The post SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven appeared first on…
This volume explores false claims suggesting abortions occur after birth, misleading narratives around the safety abortion pills, like mifepristone, and other tactics used to distort the safety of abortions. It also explores research on the acceptance of health misinformation and the proliferation of AI-generated fake news sites.
[Sponsored] Healthcare executives spoke with MedCity News on how their businesses are using tech to shape the clinician and patient experience. The post How to Build Effective Referral Networks and Improve Patient Navigation [Video] appeared first on MedCity News.
NEMT providers play a key role, providing lifelines by delivering the crucial connection between patients and the care they need. This responsibility becomes even more critical when serving individuals with special needs, such as those with physical disabilities, behavioral health conditions, developmental delays or age-related limitations. The post Its Own Reward: NEMT Services Meet Challenge…
What many organizations haven’t yet connected is how security decisions ripple through their entire financial picture, from recruitment to retention to operational efficiency. The post The Staffing Crisis Security Teams Aren’t Talking About: When Safety Concerns Drive Healthcare Worker Exodus appeared first on MedCity News.
More investors are becoming interested in digital health startups specifically targeting youth behavioral health. However, there are still more opportunities to reach youth on Medicaid. The post Funding In Youth Mental Health Is Growing. Where are the Opportunities? appeared first on MedCity News.
Measles outbreak expands to 19 states.Commercial health plan coverage of accelerated approval drugs…and a recent case study.Extending IRA drug price negotiation to commercial plans?‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism Study’Why are LLMs so good at economics?Most expensive states to start a business.
WebMD Ignite, CCS Health and Medicine for the Greater Good bring complementary strengths to rural health platform
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability. The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About…